免疫脂质体检测易破裂颅内动脉瘤
研究构建了携带抗血管炎症标志物抗体及标记物/对比剂的靶向免疫脂质体,用于动脉瘤壁炎症成像。组织学分析显示其可选择性检测动脉瘤炎症,MRI可检测携带钆的免疫脂质体。作者认为这为检测易破裂动脉瘤开辟了新途径,但需进一步研究以用于人类MRI。
要点
- 靶向免疫脂质体包含抗血管炎症标志物抗体及标记物/对比剂。
- 组织学分析显示免疫脂质体可选择性检测动脉瘤炎症。
- MRI可检测携带钆的免疫脂质体。
核心结论
- 免疫脂质体可携带钆并选择性结合动脉瘤炎症区域,可用MRI检测,为检测易破裂动脉瘤开辟新途径。
- 需进一步研究开发用于人类MRI的免疫脂质体,以靶向治疗最受益的患者。
研究设计与样本
- 研究构建了用于动脉瘤成像的靶向免疫脂质体,并进行组织学分析和MRI检测。
主要发现
- 组织学分析显示,携带抗血管炎症抗体及标记物的免疫脂质体可选择性检测动脉瘤炎症,结果令人鼓舞。
- 在MRI中能够检测携带钆的免疫脂质体。
局限性
- 需进一步研究开发用于人类MRI的免疫脂质体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is estimated that significant (3.2%) of population carries intracranial aneurysm (IA). An increasing number of imaging studies have caused that the chance of finding an incidental aneurysm is becoming more common. Since IA rupture causes subarachnoidal hemorrhage (SAH) and have significant mortality and morbidity prophylactic treatment should be considered when IA is detected. The benefit and risk of treatment of IA is based on epidemiological estimate which takes account patient and aneurysm characteristics. However we know that aneurysm rupture is biological process where inflammation of aneurysm wall is actively leading to degeneration of aneurysm wall and finally weakens it until it bursts. Until now, there have not been imaging method to detect inflammatory process of aneurysm wall METHODS: We created targeting immunoliposome for use in the imaging of aneurysm. Immunoliposome comprises antibodies against at least one vascular inflammatory marker associated with aneurysm inflammation and a label and/or a contrast agent. RESULTS: Histological analysis of IAs where immunoliposome comprises antibodies against vascular inflammation with a label shows promising results for selectively detecting aneurysms inflammation. In magnetic resonance imaging (MRI) we were able to detect immunoliposomes carrying gadolinium. CONCLUSION: Our work opens a new avenue for using contrast labeled immunoliposomes for detecting rupture-prone aneurysms. Immunoliposomes can cary gadolinium and selectively bind to inflammatory section of aneurysm that can be detected with MRI. Further research is needed to develop immunoliposomes to be used with MRI in humans to target treatment to those patients who benefit from it the most.
引用
- Jahromi BR, Zamotin V, Code C, et al. Immunoliposomes for detection of rupture-prone intracranial aneurysms. Acta Neurochir (Wien). 2023. PMID: 37749289. doi:10.1007/s00701-023-05770-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。